Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.

Codilupi T, Taube D, Naegeli H.

BMC Cancer. 2019 Nov 5;19(1):1042. doi: 10.1186/s12885-019-6305-x.

2.

Causes and risk factors for acute dialysis initiation among patients with end-stage kidney disease-a large retrospective observational cohort study.

Arulkumaran N, Navaratnarajah A, Pillay C, Brown W, Duncan N, McLean A, Taube D, Brown EA.

Clin Kidney J. 2018 Dec 22;12(4):550-558. doi: 10.1093/ckj/sfy118. eCollection 2019 Aug.

3.

Allosensitization after transplant failure: the role of graft nephrectomy and immunosuppression - a retrospective study.

Lucisano G, Brookes P, Santos-Nunez E, Firmin N, Gunby N, Hassan S, Gueret-Wardle A, Herbert P, Papalois V, Willicombe M, Taube D.

Transpl Int. 2019 Sep;32(9):949-959. doi: 10.1111/tri.13442. Epub 2019 Apr 26.

PMID:
30980556
4.

Dual-balloon assisted super-selective embolisation of high flow arterial venous fistula within a transplant kidney.

Ffrench-Constant S, Weerakoon N, Amin R, Dixon L, Taube D, Hamady M.

CVIR Endovasc. 2018;1(1):21. doi: 10.1186/s42155-018-0029-x. Epub 2018 Oct 30.

5.

Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab.

Koutroutsos K, Charif R, Moran L, Moss J, Cook T, Roufosse C, Pusey C, Taube D, Loucaidou M.

Clin Exp Nephrol. 2019 May;23(5):700-709. doi: 10.1007/s10157-019-01690-0. Epub 2019 Jan 14.

PMID:
30637591
6.

Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.

Hassan S, Regan F, Brown C, Harmer A, Anderson N, Beckwith H, Roufosse CA, Santos-Nunez E, Brookes P, Taube D, Willicombe M.

Am J Transplant. 2019 Jun;19(6):1720-1729. doi: 10.1111/ajt.15233. Epub 2019 Jan 28.

7.

Neurological complications of renal dialysis and transplantation.

Karunaratne K, Taube D, Khalil N, Perry R, Malhotra PA.

Pract Neurol. 2018 Apr;18(2):115-125. doi: 10.1136/practneurol-2017-001657. Epub 2017 Dec 28. Review.

8.

High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients.

Goodall DL, Willicombe M, McLean AG, Taube D.

Transplant Direct. 2017 Jul 7;3(8):e192. doi: 10.1097/TXD.0000000000000710. eCollection 2017 Aug.

9.

Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.

Willicombe M, Blow M, Santos-Nunez E, Freeman C, Brookes P, Taube D.

Transplantation. 2018 Jan;102(1):127-134. doi: 10.1097/TP.0000000000001887.

PMID:
28731902
10.
11.

Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids.

Prendecki M, Tanna A, Salama AD, Tam FW, Cairns T, Taube D, Cook HT, Ashby D, Duncan ND, Pusey CD.

Clin Kidney J. 2017 Apr;10(2):233-239. doi: 10.1093/ckj/sfw116. Epub 2016 Dec 24.

12.

Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol.

Willicombe M, Rizzello A, Goodall D, Papalois V, McLean AG, Taube D.

World J Transplant. 2017 Feb 24;7(1):34-42. doi: 10.5500/wjt.v7.i1.34.

13.

Use of non-irradiated blood components in Campath (alemtuzumab)-treated renal transplant patients.

Hui YM, Regan F, Willecombe M, Taube D.

Transfus Med. 2016 Apr;26(2):138-46. doi: 10.1111/tme.12292. Epub 2016 Mar 21.

PMID:
26996635
14.

Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies.

Willicombe M, Moss J, Moran L, Brookes P, Santos-Nunez E, McLean AG, Cairns T, Taube D, Cook TH, Roufosse C.

J Am Soc Nephrol. 2016 Jul;27(7):2188-95. doi: 10.1681/ASN.2015050478. Epub 2015 Nov 27.

15.

Transcatheter aortic valve implantation in the young.

Panoulas VF, Sutaria N, Sen S, Frame A, Ariff B, Gopalan D, Galliford J, Taube D, Malik IS, Mikhail GW.

Int J Cardiol. 2016 Jan 15;203:626-8. doi: 10.1016/j.ijcard.2015.10.243. Epub 2015 Nov 5. No abstract available.

PMID:
26580345
16.

Peritubular Capillary Basement Membrane Multilayering in Renal Allograft Biopsies of Patients With De Novo Donor-Specific Antibodies.

de Kort H, Willicombe M, Brookes P, Moran LB, Santos-Nunez E, Galliford JW, Taube D, McLean AG, Moss J, Cook HT, Roufosse C.

Transplantation. 2016 Apr;100(4):889-97. doi: 10.1097/TP.0000000000000908.

PMID:
26413993
17.

A Systematic Review of Outcomes Following Percutaneous Transluminal Angioplasty and Stenting in the Treatment of Transplant Renal Artery Stenosis.

Ngo AT, Markar SR, De Lijster MS, Duncan N, Taube D, Hamady MS.

Cardiovasc Intervent Radiol. 2015 Dec;38(6):1573-88. doi: 10.1007/s00270-015-1134-z. Epub 2015 Jun 19. Review.

PMID:
26088719
18.

B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection.

Shiu KY, McLaughlin L, Rebollo-Mesa I, Zhao J, Semik V, Cook HT, Roufosse C, Brookes P, Bowers RW, Galliford J, Taube D, Lechler RI, Hernandez-Fuentes MP, Dorling A.

Kidney Int. 2015 Sep;88(3):560-8. doi: 10.1038/ki.2015.100. Epub 2015 Apr 1.

19.

Use of Quantitative Real Time Polymerase Chain Reaction to Assess Gene Transcripts Associated With Antibody-Mediated Rejection of Kidney Transplants.

Dominy KM, Roufosse C, de Kort H, Willicombe M, Brookes P, Behmoaras JV, Petretto EG, Galliford J, Choi P, Taube D, Cook HT, Mclean AG.

Transplantation. 2015 Sep;99(9):1981-8. doi: 10.1097/TP.0000000000000621.

20.

Incidence, risk factors, and outcomes of stroke post-transplantation in patients receiving a steroid sparing immunosuppression protocol.

Willicombe M, Kumar N, Goodall D, Clarke C, McLean AG, Power A, Taube D.

Clin Transplant. 2015 Jan;29(1):18-25. doi: 10.1111/ctr.12476. Epub 2014 Nov 19.

PMID:
25307366
21.

Generic tacrolimus in solid organ transplantation.

Taube D, Jones G, O'Beirne J, Wennberg L, Connor A, Rasmussen A, Backman L.

Clin Transplant. 2014 May;28(5):623-32. doi: 10.1111/ctr.12336. Epub 2014 Apr 21. Review.

PMID:
24750309
22.

Comparison of Tesio and LifeCath twin permanent hemodialysis catheters: the VyTes randomized trial.

Power A, Hill P, Singh SK, Ashby D, Taube D, Duncan N.

J Vasc Access. 2014 Mar-Apr;15(2):108-15. doi: 10.5301/jva.5000202. Epub 2014 Feb 5.

PMID:
24500851
23.

Acute cellular rejection: impact of donor-specific antibodies and C4d.

Willicombe M, Roufosse C, Brookes P, McLean AG, Galliford J, Cairns T, Cook TH, Taube D.

Transplantation. 2014 Feb 27;97(4):433-9. doi: 10.1097/01.TP.0000437431.97108.8f.

PMID:
24430742
24.

Postanastomotic transplant renal artery stenosis: association with de novo class II donor-specific antibodies.

Willicombe M, Sandhu B, Brookes P, Gedroyc W, Hakim N, Hamady M, Hill P, McLean AG, Moser S, Papalois V, Tait P, Wilcock M, Taube D.

Am J Transplant. 2014 Jan;14(1):133-43. doi: 10.1111/ajt.12531.

25.

Fractalkine depresses cardiomyocyte contractility.

Taube D, Xu J, Yang XP, Undrovinas A, Peterson E, Harding P.

PLoS One. 2013 Jul 30;8(7):e69832. doi: 10.1371/journal.pone.0069832. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/8ea7695c-59d1-43c4-809b-fe021e07c799.

26.

Screening for transient ischemic attacks in hemodialysis patients.

Power A, Edwards C, Sawyer J, Tandaric D, Dahdaleh D, Taube D, Duncan N.

J Nephrol. 2013 Sep-Oct;26(5):919-24. doi: 10.5301/jn.5000250. Epub 2013 May 23.

PMID:
23807647
27.

Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.

Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.

Cerebrovasc Dis. 2013;35(1):45-52. doi: 10.1159/000345071. Epub 2013 Feb 14.

PMID:
23428996
28.

Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.

Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.

Transplantation. 2013 Jan 27;95(2):341-6. doi: 10.1097/TP.0b013e3182743cfa.

PMID:
23197178
29.

Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.

de Kort H, Willicombe M, Brookes P, Dominy KM, Santos-Nunez E, Galliford JW, Chan K, Taube D, McLean AG, Cook HT, Roufosse C.

Am J Transplant. 2013 Feb;13(2):485-92. doi: 10.1111/j.1600-6143.2012.04325.x. Epub 2012 Nov 21.

30.

Ten-year patient survival on maintenance haemodialysis: association with treatment time and dialysis dose.

Singh S, Choi P, Power A, Ashby D, Cairns T, Griffith M, McLean A, Palmer A, Taube D, Duncan N.

J Nephrol. 2013 Jul-Aug;26(4):763-70. doi: 10.5301/jn.5000234. Epub 2012 Nov 7.

PMID:
23147685
31.

Glibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.

Zhu L, Cortes P, Hassett C, Taube DW, Yee J.

Exp Diabetes Res. 2012;2012:183535. Epub 2012 Sep 12.

32.

Renal allograft recipients fail to increase interferon-γ during invasive fungal diseases.

Armstrong-James D, Teo I, Herbst S, Petrou M, Shiu KY, McLean A, Taube D, Dorling A, Shaunak S.

Am J Transplant. 2012 Dec;12(12):3437-40. doi: 10.1111/j.1600-6143.2012.04254.x. Epub 2012 Sep 13.

33.

Peritubular capillary basement membrane multilayering on electron microscopy: a useful marker of early chronic antibody-mediated damage.

Roufosse CA, Shore I, Moss J, Moran LB, Willicombe M, Galliford J, Chan KK, Brookes PA, de Kort H, McLean AG, Taube D, Cook HT.

Transplantation. 2012 Aug 15;94(3):269-74.

PMID:
22790448
34.

De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.

Willicombe M, Brookes P, Sergeant R, Santos-Nunez E, Steggar C, Galliford J, McLean A, Cook TH, Cairns T, Roufosse C, Taube D.

Transplantation. 2012 Jul 27;94(2):172-7. doi: 10.1097/TP.0b013e3182543950.

PMID:
22735711
35.

A case of chronic antibody-mediated rejection in the making.

Bravou V, Galliford J, McLean A, Willicombe M, Taube D, Cook HT, Roufosse C.

Clin Nephrol. 2013 Oct;80(4):306-9. doi: 10.5414/CN107462.

PMID:
22579273
36.

Expanding the donor pool: living donor nephrectomy in the elderly and the overweight.

O'Brien B, Mastoridis S, Sabharwal A, Hakim N, Taube D, Papalois V.

Transplantation. 2012 Jun 15;93(11):1158-65. doi: 10.1097/TP.0b013e31824ef1ae.

PMID:
22495495
37.

Is there a role for free breathing non-contrast steady-state free precession renal MRA imaging for assessing live donors? A preliminary study.

Laurence I, Ariff B, Quest RA, Moser S, Glover A, Taube D, Gishen P, Papalois V, Juli C.

Br J Radiol. 2012 Aug;85(1016):e448-54. doi: 10.1259/bjr/16270927. Epub 2012 Jan 17.

38.

Renal transplantation.

Thiruchelvam PT, Willicombe M, Hakim N, Taube D, Papalois V.

BMJ. 2011 Nov 14;343:d7300. doi: 10.1136/bmj.d7300. Review. No abstract available.

PMID:
22084316
39.

Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic?

Lawrence C, Galliford JW, Willicombe MK, McLean AG, Lesabe M, Rowan F, Papalois V, Regan F, Taube D.

Transplantation. 2011 Nov 27;92(10):1129-33. doi: 10.1097/TP.0b013e31823360cf.

PMID:
21959216
40.

Long-term renal function and survival of renal transplant recipients admitted to the intensive care unit.

Arulkumaran N, West S, Chan K, Templeton M, Taube D, Brett SJ.

Clin Transplant. 2012 Jan-Feb;26(1):E24-31. doi: 10.1111/j.1399-0012.2011.01520.x. Epub 2011 Sep 29.

PMID:
21955177
41.

Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study.

Power A, Chan K, Singh SK, Taube D, Duncan N.

Am J Kidney Dis. 2012 Feb;59(2):249-57. doi: 10.1053/j.ajkd.2011.07.016. Epub 2011 Sep 23.

PMID:
21944665
42.

When is differential treatment discriminatory? Legal, ethical, and professional considerations for psychology trainees with disabilities.

Taube DO, Olkin R.

Rehabil Psychol. 2011 Nov;56(4):329-39. doi: 10.1037/a0025449. Epub 2011 Sep 19. Review.

PMID:
21928920
43.

Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial.

Chan K, Taube D, Roufosse C, Cook T, Brookes P, Goodall D, Galliford J, Cairns T, Dorling A, Duncan N, Hakim N, Palmer A, Papalois V, Warrens AN, Willicombe M, McLean AG.

Transplantation. 2011 Oct 15;92(7):774-80. doi: 10.1097/TP.0b013e31822ca7ca.

PMID:
21836540
44.

Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation.

Kumar N, Baker CS, Chan K, Duncan N, Malik I, Frankel A, Ashby DR, McLean A, Palmer A, Cairns TD, Taube D.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1912-9. doi: 10.2215/CJN.08680910. Epub 2011 Jul 7.

45.

Malignancies confined to disused arteriovenous fistulae in renal transplant patients: an important differential diagnosis.

Webster P, Wujanto L, Fisher C, Walker M, Ramakrishnan R, Naresh K, Thomas JM, Papalois V, Crane J, Taube D, Duncan N.

Am J Nephrol. 2011;34(1):42-8. doi: 10.1159/000328908. Epub 2011 Jun 10.

46.

Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome.

Willicombe M, Roufosse C, Brookes P, Galliford JW, McLean AG, Dorling A, Warrens AN, Cook TH, Cairns TD, Taube D.

Transplantation. 2011 Jul 27;92(2):176-82. doi: 10.1097/TP.0b013e318222c9c6.

PMID:
21637139
47.

Long-term Tesio catheter access for hemodialysis can deliver high dialysis adequacy with low complication rates.

Power A, Singh SK, Ashby D, Cairns T, Taube D, Duncan N.

J Vasc Interv Radiol. 2011 May;22(5):631-7. doi: 10.1016/j.jvir.2010.12.034. Epub 2011 Mar 17.

PMID:
21419650
48.

Intracranial arterial calcification is highly prevalent in hemodialysis patients but does not associate with acute ischemic stroke.

Power A, Chan K, Haydar A, Hamady M, Cairns T, Taube D, Duncan N.

Hemodial Int. 2011 Apr;15(2):256-63. doi: 10.1111/j.1542-4758.2011.00543.x. Epub 2011 Mar 16.

PMID:
21410636
49.

Renal artery stenosis: comparative assessment by unenhanced renal artery MRA versus contrast-enhanced MRA.

Khoo MM, Deeab D, Gedroyc WM, Duncan N, Taube D, Dick EA.

Eur Radiol. 2011 Jul;21(7):1470-6. doi: 10.1007/s00330-011-2086-6. Epub 2011 Feb 20.

PMID:
21337034
50.

Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy.

Willicombe M, Brookes P, Santos-Nunez E, Galliford J, Ballow A, Mclean A, Roufosse C, Cook HT, Dorling A, Warrens AN, Cairns T, Taube D.

Am J Transplant. 2011 Mar;11(3):470-7. doi: 10.1111/j.1600-6143.2010.03421.x. Epub 2011 Feb 7.

Supplemental Content

Support Center